Current Issues in the Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop

Objective: This report summarizes data on traditional and nontraditional manifestations of primary hyperparathyroidism (PHPT) that have been published since the last International Workshop on PHPT. Participants: This subgroup was constituted by the Steering Committee to address key questions related...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical endocrinology and metabolism 2014-10, Vol.99 (10), p.3580-3594
Hauptverfasser: Silverberg, Shonni J, Clarke, Bart L, Peacock, Munro, Bandeira, Francisco, Boutroy, Stephanie, Cusano, Natalie E, Dempster, David, Lewiecki, E. Michael, Liu, Jian-Min, Minisola, Salvatore, Rejnmark, Lars, Silva, Barbara C, Walker, Marcella D, Bilezikian, John P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3594
container_issue 10
container_start_page 3580
container_title The Journal of clinical endocrinology and metabolism
container_volume 99
creator Silverberg, Shonni J
Clarke, Bart L
Peacock, Munro
Bandeira, Francisco
Boutroy, Stephanie
Cusano, Natalie E
Dempster, David
Lewiecki, E. Michael
Liu, Jian-Min
Minisola, Salvatore
Rejnmark, Lars
Silva, Barbara C
Walker, Marcella D
Bilezikian, John P
description Objective: This report summarizes data on traditional and nontraditional manifestations of primary hyperparathyroidism (PHPT) that have been published since the last International Workshop on PHPT. Participants: This subgroup was constituted by the Steering Committee to address key questions related to the presentation of PHPT. Consensus was established at a closed meeting of the Expert Panel that followed. Evidence: Data from the 5-year period between 2008 and 2013 were presented and discussed to determine whether they support changes in recommendations for surgery or nonsurgical follow-up. Consensus Process: Questions were developed by the International Task Force on PHPT. A comprehensive literature search for relevant studies was undertaken. After extensive review and discussion, the subgroup came to agreement on what changes in the recommendations for surgery or nonsurgical follow-up of asymptomatic PHPT should be made to the Expert Panel. Conclusions: 1) There are limited new data available on the natural history of asymptomatic PHPT. Although recognition of normocalcemic PHPT (normal serum calcium with elevated PTH concentrations; no secondary cause for hyperparathyroidism) is increasing, data on the clinical presentation and natural history of this phenotype are limited. 2) Although there are geographic differences in the predominant phenotypes of PHPT (symptomatic, asymptomatic, normocalcemic), they do not justify geography-specific management guidelines. 3) Recent data using newer, higher resolution imaging and analytic methods have revealed that in asymptomatic PHPT, both trabecular bone and cortical bone are affected. 4) Clinically silent nephrolithiasis and nephrocalcinosis can be detected by renal imaging and should be listed as a new criterion for surgery. 5) Current data do not support a cardiovascular evaluation or surgery for the purpose of improving cardiovascular markers, anatomical or functional abnormalities. 6) Some patients with mild PHPT have neuropsychological complaints and cognitive abnormalities, and some of these patients may benefit from surgical intervention. However, it is not possible at this time to predict which patients with neuropsychological complaints or cognitive issues will improve after successful parathyroid surgery.
doi_str_mv 10.1210/jc.2014-1415
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5393491</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1586101138</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4734-c3f561ab867ec05f33501983ab6a9b6c422005622f2b4eff3ca33122062fbf63</originalsourceid><addsrcrecordid>eNptkU1v1DAQhi0EokvhxhnlyIEUj7-ScECqVpSuVAkOleBmOV678Taxg5202hs_HYeUCiR8sTzzzuuZeRB6DfgMCOD3B31GMLASGPAnaAMN42UFTfUUbTAmUDYV-X6CXqR0wFnGOH2OTggHQYSoNujndo7R-KnYpTSbVDhfTJ0pvkaTclRNLvgi2OI8HYdxCkMO6Jx0g4rH4vI4mjiqqKbuGIPbuzR8yMmgjdk7f5OWwsXsIsxx6oqdn0z0vy1VX3wL8TZ1YXyJnlnVJ_Pq4T5F1xefrreX5dWXz7vt-VWpWUVZqanlAlRbi8pozC2lHENTU9UK1bRCM0Iw5oIQS1pmrKVaUQo5KIhtraCn6ONqO87tYPY6DxdVL8d1FBmUk_9mvOvkTbiTnDaUNZAN3j4YxPAjb2qSg0va9L3yJsxJAq8FYABaZ-m7VapjSCka-_gNYLkwkwctF2ZyYZblb_5u7VH8B1IWsFVwH_q8wnTbz_cmys6ofuokzoeJqi4XR1heJV5I5zK6lhm_Dzo6b8ZMNclDxpEJpP938wt4o7Ze</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1586101138</pqid></control><display><type>article</type><title>Current Issues in the Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Silverberg, Shonni J ; Clarke, Bart L ; Peacock, Munro ; Bandeira, Francisco ; Boutroy, Stephanie ; Cusano, Natalie E ; Dempster, David ; Lewiecki, E. Michael ; Liu, Jian-Min ; Minisola, Salvatore ; Rejnmark, Lars ; Silva, Barbara C ; Walker, Marcella D ; Bilezikian, John P</creator><creatorcontrib>Silverberg, Shonni J ; Clarke, Bart L ; Peacock, Munro ; Bandeira, Francisco ; Boutroy, Stephanie ; Cusano, Natalie E ; Dempster, David ; Lewiecki, E. Michael ; Liu, Jian-Min ; Minisola, Salvatore ; Rejnmark, Lars ; Silva, Barbara C ; Walker, Marcella D ; Bilezikian, John P</creatorcontrib><description>Objective: This report summarizes data on traditional and nontraditional manifestations of primary hyperparathyroidism (PHPT) that have been published since the last International Workshop on PHPT. Participants: This subgroup was constituted by the Steering Committee to address key questions related to the presentation of PHPT. Consensus was established at a closed meeting of the Expert Panel that followed. Evidence: Data from the 5-year period between 2008 and 2013 were presented and discussed to determine whether they support changes in recommendations for surgery or nonsurgical follow-up. Consensus Process: Questions were developed by the International Task Force on PHPT. A comprehensive literature search for relevant studies was undertaken. After extensive review and discussion, the subgroup came to agreement on what changes in the recommendations for surgery or nonsurgical follow-up of asymptomatic PHPT should be made to the Expert Panel. Conclusions: 1) There are limited new data available on the natural history of asymptomatic PHPT. Although recognition of normocalcemic PHPT (normal serum calcium with elevated PTH concentrations; no secondary cause for hyperparathyroidism) is increasing, data on the clinical presentation and natural history of this phenotype are limited. 2) Although there are geographic differences in the predominant phenotypes of PHPT (symptomatic, asymptomatic, normocalcemic), they do not justify geography-specific management guidelines. 3) Recent data using newer, higher resolution imaging and analytic methods have revealed that in asymptomatic PHPT, both trabecular bone and cortical bone are affected. 4) Clinically silent nephrolithiasis and nephrocalcinosis can be detected by renal imaging and should be listed as a new criterion for surgery. 5) Current data do not support a cardiovascular evaluation or surgery for the purpose of improving cardiovascular markers, anatomical or functional abnormalities. 6) Some patients with mild PHPT have neuropsychological complaints and cognitive abnormalities, and some of these patients may benefit from surgical intervention. However, it is not possible at this time to predict which patients with neuropsychological complaints or cognitive issues will improve after successful parathyroid surgery.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.2014-1415</identifier><identifier>PMID: 25162667</identifier><language>eng</language><publisher>United States: Endocrine Society</publisher><subject>Asymptomatic Diseases ; Education ; Endocrinology - standards ; Evidence-Based Medicine - standards ; Humans ; Hyperparathyroidism, Primary - diagnosis ; Hyperparathyroidism, Primary - surgery</subject><ispartof>The Journal of clinical endocrinology and metabolism, 2014-10, Vol.99 (10), p.3580-3594</ispartof><rights>Copyright © 2014 by the Endocrine Society</rights><rights>Copyright © 2014 by The Endocrine Society</rights><rights>Copyright © 2014 by the Endocrine Society 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4734-c3f561ab867ec05f33501983ab6a9b6c422005622f2b4eff3ca33122062fbf63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,310,311,315,782,786,791,792,887,23937,23938,25147,27931,27932</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25162667$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Silverberg, Shonni J</creatorcontrib><creatorcontrib>Clarke, Bart L</creatorcontrib><creatorcontrib>Peacock, Munro</creatorcontrib><creatorcontrib>Bandeira, Francisco</creatorcontrib><creatorcontrib>Boutroy, Stephanie</creatorcontrib><creatorcontrib>Cusano, Natalie E</creatorcontrib><creatorcontrib>Dempster, David</creatorcontrib><creatorcontrib>Lewiecki, E. Michael</creatorcontrib><creatorcontrib>Liu, Jian-Min</creatorcontrib><creatorcontrib>Minisola, Salvatore</creatorcontrib><creatorcontrib>Rejnmark, Lars</creatorcontrib><creatorcontrib>Silva, Barbara C</creatorcontrib><creatorcontrib>Walker, Marcella D</creatorcontrib><creatorcontrib>Bilezikian, John P</creatorcontrib><title>Current Issues in the Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop</title><title>The Journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Objective: This report summarizes data on traditional and nontraditional manifestations of primary hyperparathyroidism (PHPT) that have been published since the last International Workshop on PHPT. Participants: This subgroup was constituted by the Steering Committee to address key questions related to the presentation of PHPT. Consensus was established at a closed meeting of the Expert Panel that followed. Evidence: Data from the 5-year period between 2008 and 2013 were presented and discussed to determine whether they support changes in recommendations for surgery or nonsurgical follow-up. Consensus Process: Questions were developed by the International Task Force on PHPT. A comprehensive literature search for relevant studies was undertaken. After extensive review and discussion, the subgroup came to agreement on what changes in the recommendations for surgery or nonsurgical follow-up of asymptomatic PHPT should be made to the Expert Panel. Conclusions: 1) There are limited new data available on the natural history of asymptomatic PHPT. Although recognition of normocalcemic PHPT (normal serum calcium with elevated PTH concentrations; no secondary cause for hyperparathyroidism) is increasing, data on the clinical presentation and natural history of this phenotype are limited. 2) Although there are geographic differences in the predominant phenotypes of PHPT (symptomatic, asymptomatic, normocalcemic), they do not justify geography-specific management guidelines. 3) Recent data using newer, higher resolution imaging and analytic methods have revealed that in asymptomatic PHPT, both trabecular bone and cortical bone are affected. 4) Clinically silent nephrolithiasis and nephrocalcinosis can be detected by renal imaging and should be listed as a new criterion for surgery. 5) Current data do not support a cardiovascular evaluation or surgery for the purpose of improving cardiovascular markers, anatomical or functional abnormalities. 6) Some patients with mild PHPT have neuropsychological complaints and cognitive abnormalities, and some of these patients may benefit from surgical intervention. However, it is not possible at this time to predict which patients with neuropsychological complaints or cognitive issues will improve after successful parathyroid surgery.</description><subject>Asymptomatic Diseases</subject><subject>Education</subject><subject>Endocrinology - standards</subject><subject>Evidence-Based Medicine - standards</subject><subject>Humans</subject><subject>Hyperparathyroidism, Primary - diagnosis</subject><subject>Hyperparathyroidism, Primary - surgery</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkU1v1DAQhi0EokvhxhnlyIEUj7-ScECqVpSuVAkOleBmOV678Taxg5202hs_HYeUCiR8sTzzzuuZeRB6DfgMCOD3B31GMLASGPAnaAMN42UFTfUUbTAmUDYV-X6CXqR0wFnGOH2OTggHQYSoNujndo7R-KnYpTSbVDhfTJ0pvkaTclRNLvgi2OI8HYdxCkMO6Jx0g4rH4vI4mjiqqKbuGIPbuzR8yMmgjdk7f5OWwsXsIsxx6oqdn0z0vy1VX3wL8TZ1YXyJnlnVJ_Pq4T5F1xefrreX5dWXz7vt-VWpWUVZqanlAlRbi8pozC2lHENTU9UK1bRCM0Iw5oIQS1pmrKVaUQo5KIhtraCn6ONqO87tYPY6DxdVL8d1FBmUk_9mvOvkTbiTnDaUNZAN3j4YxPAjb2qSg0va9L3yJsxJAq8FYABaZ-m7VapjSCka-_gNYLkwkwctF2ZyYZblb_5u7VH8B1IWsFVwH_q8wnTbz_cmys6ofuokzoeJqi4XR1heJV5I5zK6lhm_Dzo6b8ZMNclDxpEJpP938wt4o7Ze</recordid><startdate>201410</startdate><enddate>201410</enddate><creator>Silverberg, Shonni J</creator><creator>Clarke, Bart L</creator><creator>Peacock, Munro</creator><creator>Bandeira, Francisco</creator><creator>Boutroy, Stephanie</creator><creator>Cusano, Natalie E</creator><creator>Dempster, David</creator><creator>Lewiecki, E. Michael</creator><creator>Liu, Jian-Min</creator><creator>Minisola, Salvatore</creator><creator>Rejnmark, Lars</creator><creator>Silva, Barbara C</creator><creator>Walker, Marcella D</creator><creator>Bilezikian, John P</creator><general>Endocrine Society</general><general>Copyright by The Endocrine Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201410</creationdate><title>Current Issues in the Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop</title><author>Silverberg, Shonni J ; Clarke, Bart L ; Peacock, Munro ; Bandeira, Francisco ; Boutroy, Stephanie ; Cusano, Natalie E ; Dempster, David ; Lewiecki, E. Michael ; Liu, Jian-Min ; Minisola, Salvatore ; Rejnmark, Lars ; Silva, Barbara C ; Walker, Marcella D ; Bilezikian, John P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4734-c3f561ab867ec05f33501983ab6a9b6c422005622f2b4eff3ca33122062fbf63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Asymptomatic Diseases</topic><topic>Education</topic><topic>Endocrinology - standards</topic><topic>Evidence-Based Medicine - standards</topic><topic>Humans</topic><topic>Hyperparathyroidism, Primary - diagnosis</topic><topic>Hyperparathyroidism, Primary - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Silverberg, Shonni J</creatorcontrib><creatorcontrib>Clarke, Bart L</creatorcontrib><creatorcontrib>Peacock, Munro</creatorcontrib><creatorcontrib>Bandeira, Francisco</creatorcontrib><creatorcontrib>Boutroy, Stephanie</creatorcontrib><creatorcontrib>Cusano, Natalie E</creatorcontrib><creatorcontrib>Dempster, David</creatorcontrib><creatorcontrib>Lewiecki, E. Michael</creatorcontrib><creatorcontrib>Liu, Jian-Min</creatorcontrib><creatorcontrib>Minisola, Salvatore</creatorcontrib><creatorcontrib>Rejnmark, Lars</creatorcontrib><creatorcontrib>Silva, Barbara C</creatorcontrib><creatorcontrib>Walker, Marcella D</creatorcontrib><creatorcontrib>Bilezikian, John P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silverberg, Shonni J</au><au>Clarke, Bart L</au><au>Peacock, Munro</au><au>Bandeira, Francisco</au><au>Boutroy, Stephanie</au><au>Cusano, Natalie E</au><au>Dempster, David</au><au>Lewiecki, E. Michael</au><au>Liu, Jian-Min</au><au>Minisola, Salvatore</au><au>Rejnmark, Lars</au><au>Silva, Barbara C</au><au>Walker, Marcella D</au><au>Bilezikian, John P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current Issues in the Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop</atitle><jtitle>The Journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2014-10</date><risdate>2014</risdate><volume>99</volume><issue>10</issue><spage>3580</spage><epage>3594</epage><pages>3580-3594</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><abstract>Objective: This report summarizes data on traditional and nontraditional manifestations of primary hyperparathyroidism (PHPT) that have been published since the last International Workshop on PHPT. Participants: This subgroup was constituted by the Steering Committee to address key questions related to the presentation of PHPT. Consensus was established at a closed meeting of the Expert Panel that followed. Evidence: Data from the 5-year period between 2008 and 2013 were presented and discussed to determine whether they support changes in recommendations for surgery or nonsurgical follow-up. Consensus Process: Questions were developed by the International Task Force on PHPT. A comprehensive literature search for relevant studies was undertaken. After extensive review and discussion, the subgroup came to agreement on what changes in the recommendations for surgery or nonsurgical follow-up of asymptomatic PHPT should be made to the Expert Panel. Conclusions: 1) There are limited new data available on the natural history of asymptomatic PHPT. Although recognition of normocalcemic PHPT (normal serum calcium with elevated PTH concentrations; no secondary cause for hyperparathyroidism) is increasing, data on the clinical presentation and natural history of this phenotype are limited. 2) Although there are geographic differences in the predominant phenotypes of PHPT (symptomatic, asymptomatic, normocalcemic), they do not justify geography-specific management guidelines. 3) Recent data using newer, higher resolution imaging and analytic methods have revealed that in asymptomatic PHPT, both trabecular bone and cortical bone are affected. 4) Clinically silent nephrolithiasis and nephrocalcinosis can be detected by renal imaging and should be listed as a new criterion for surgery. 5) Current data do not support a cardiovascular evaluation or surgery for the purpose of improving cardiovascular markers, anatomical or functional abnormalities. 6) Some patients with mild PHPT have neuropsychological complaints and cognitive abnormalities, and some of these patients may benefit from surgical intervention. However, it is not possible at this time to predict which patients with neuropsychological complaints or cognitive issues will improve after successful parathyroid surgery.</abstract><cop>United States</cop><pub>Endocrine Society</pub><pmid>25162667</pmid><doi>10.1210/jc.2014-1415</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-972X
ispartof The Journal of clinical endocrinology and metabolism, 2014-10, Vol.99 (10), p.3580-3594
issn 0021-972X
1945-7197
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5393491
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Asymptomatic Diseases
Education
Endocrinology - standards
Evidence-Based Medicine - standards
Humans
Hyperparathyroidism, Primary - diagnosis
Hyperparathyroidism, Primary - surgery
title Current Issues in the Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T16%3A00%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20Issues%20in%20the%20Presentation%20of%20Asymptomatic%20Primary%20Hyperparathyroidism:%20Proceedings%20of%20the%20Fourth%20International%20Workshop&rft.jtitle=The%20Journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Silverberg,%20Shonni%20J&rft.date=2014-10&rft.volume=99&rft.issue=10&rft.spage=3580&rft.epage=3594&rft.pages=3580-3594&rft.issn=0021-972X&rft.eissn=1945-7197&rft_id=info:doi/10.1210/jc.2014-1415&rft_dat=%3Cproquest_pubme%3E1586101138%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1586101138&rft_id=info:pmid/25162667&rfr_iscdi=true